Physician profile
John S Mullen
NPI 1013982636
$435.04
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $91.63 · 2021: $3.82 · 2023: $17.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $17.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $17.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $171.07 | 2019 | |
| Astellas Pharma US INC | $71.81 | 2019-2020 | |
| Coloplast Corp | $67.68 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $49.40 | 2019 | |
| Convatec INC. | $26.90 | 2019 | |
| Endo Pharmaceuticals INC. | $25.41 | 2019 | |
| Intuitive Surgical, INC. | $17.64 | 2023 | Da Vinci Surgical System |
| Travere Therapeutics, INC. | $5.13 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.